Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli.

To evaluate the sensitivity of peak expiratory flow (PEF), obtained by portable peak flow meter, in detecting mild changes in airway caliber as assessed by forced expiratory volume in 1 sec (FEV1), we studied 184 subjects who underwent different bronchial challenge tests for suspected bronchial asthma. We measured FEV1 and PEF during bronchoconstriction induced by different stimuli: allergen, methacholine, toluene diisocyanate vapors, exercise, or distilled water inhalation; a total of 186 tests were examined. Before and at different times after challenge, FEV1 was measured, and immediately after, PEF was obtained by Mini-Wright or Assess Peak Flow Meter; each time FEV1 and PEF were taken as the best of three satisfactory tracings. The median FEV1 change from baseline value of all steps in the different challenge tests was 7.5% (range: 0-66%). The correlation coefficients between FEV1 and PEF percent changes in different challenge tests were low (Spearman's p: 0.27-0.69), with high scattering of the data. The concordance between classes of percent changes in FEV1 and PEF was also low (Cohen's weighted kappa: 0.28-0.42). In subjects with a FEV1 fall > 15% after challenge, the median PEF change after bronchoconstriction was lower than the corresponding FEV1 change [17% (0-52) vs. 27% (17-66)]. When different cutoff limits of PEF percent change were considered, the sensitivity of PEF to detect a significant change in FEV1 (15 or 20% change) during bronchoconstriction was low; specificity was in general higher than sensitivity. We conclude that PEF and FEV1 changes are poorly related during mild bronchoconstriction induced by different stimuli. The low sensitivity of PEF to detect mild changes in airway caliber may represent a limit in the use of PEF in the day-to-day monitoring of asthma.

[1]  A. Jackson.  Accuracy, reproducibility, and variability of portable peak flowmeters. , 1995, Chest.

[2]  J. Malo,et al.  Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. , 1994, Chest.

[3]  D. Strachan,et al.  The relationship of salivary cotinine to respiratory symptoms, spirometry, and exercise-induced bronchospasm in seven-year-old children. , 1990, The American review of respiratory disease.

[4]  J. Malo,et al.  Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers. , 1991, Chest.

[5]  G. Gibson,et al.  Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. , 1988, Thorax.

[6]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[7]  M. Turner‐Warwick.  On observing patterns of airflow obstruction in chronic asthma. , 1977, British journal of diseases of the chest.

[8]  H. Nelson,et al.  Comparison of PEFR and FEV1 in patients with varying degrees of airway obstruction. Effect of modest altitude. , 1989, Chest.

[9]  Partridge,et al.  International Consensus Report on Diagnosis and Treatment of Asthma. , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  R. Harrist,et al.  An assessment of peak expiratory flow as a surrogate measurement of FEV1 in stable asthmatic children. , 1989, Chest.

[11]  J. Nadel,et al.  Effect of a previous deep inspiration on airway resistance in man. , 1961, Journal of applied physiology.

[12]  B. Sundblad,et al.  Importance of the time interval between FEV1 measurements in a methacholine provocation test. , 1993, The European respiratory journal.

[13]  G. Moscato,et al.  Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics. , 1991, The American review of respiratory disease.

[14]  M. Lebowitz,et al.  The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. , 2015, The American review of respiratory disease.

[15]  C. Giuntini,et al.  Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. , 1991, Respiratory medicine.

[16]  C. Giuntini,et al.  Atropine does not inhibit late asthmatic responses induced by toluene-diisocyanate in sensitized subjects. , 1987, The American review of respiratory disease.